Walder Wyss advised Alentis Therapeutics AG on the deal. Alentis Therapeutics AG announced a USD 67m series B financing round. Morningside Venture Investments led the financing, joined…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
